Cancer Advocates to Convene on Beacon Hill to Urge Lawmakers to Reduce Health Disparities
Cancer survivors and caregivers urge lawmakers to support legislation that will increase access to precision medicine through biomarker testing.
Acceso a las Pruebas de Biomarcadores Press Releases
Defensores de la salud pública se unen para aplaudir al Senado e instan a la Asamblea y a la gobernadora Hochul a “rechazar el retroceso”
Hoy temprano, una coalición liderada por la Red de Acción contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN), formada por defensores de los pacientes, promotores legislativos, líderes de salud pública y sobrevivientes de cáncer preocupados, se reunió para aplaudir al Senado y pedir a la gobernadora Hochul y al liderazgo de la Asamblea que se unan al Senado para preservar el acceso de los beneficiarios de Medicaid a las pruebas de biomarcadores.
DozCancer Advocates Celebrate as Governor Signs “Jill’s Law” for Biomarker Testing Coverage
JACKSON, Miss. – Cancer advocates are celebrating after Gov.
‘Delaware Advocacy Day’ Brings Patient Advocates to Dover to Discuss Affordability of Biomarker Testing
Earlier today, cancer survivors, medical professionals and patient advocates from across Delaware convened in Dover at Legislative Hall as a part of ‘Delaware Advocacy Day.’ The main focus of Advocacy Day, which was hosted by the American Cancer Society Cancer Action Network (ACS CAN) and the Alzheimer’s Association (ALZ), was for volunteers to connect directly with legislators and ask for their support of Senate Bill 120, a bipartisan proposal to improve Delawareans’ access to biomarker testing.
NYS Senate Rejects Medicaid Rollback of Biomarker Testing Coverage Criteria, Patient Advocates Urge Governor & Assembly to Follow Suit in Final Budget
The one-house budget proposals revealed a clear divide in the Legislature’s approach to the equitable treatment of disease. The New York State Senate flatly rejected the governor’s proposal to roll back Medicaid coverage criteria for biomarker testing, heeding the calls of cancer survivors, patient advocates and public health organizations, like the American Cancer Society Cancer Action Network (ACS CAN). The Assembly took a more mixed approach accepting parts of the Governor’s proposed language while rejecting others.
Mississippi Senate Passes “Jill’s Law,” Sending Biomarker Testing Coverage Bill to Governor’s Desk
JACKSON, Miss. – The Mississippi Senate passed “Jill’s Law” House Bill 565 Wednesday, paving the way for increased access to biomarker testing for Mississippians with state-regulated he
Mississippi Senate Passes Biomarker Testing Coverage Bill
JACKSON, Miss. – The Mississippi Senate passed Senate Bill 2694 Wednesday, February 11, paving the way for increased access to biomarker testing for patients across the Magnolia State.
Defensores de pacientes piden proteger el acceso a la medicina de precisión en Medicaid
Más de una docena de voluntarios de ACS CAN se reunieron en el Capitolio de Nueva York para instar a los legisladores a que preserven el acceso a las pruebas de biomarcadores, una prioridad para más de 100 organizaciones.